Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer

Benzer Materyaller

• Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
  Yazar:: Sah, Birendra Kumar, ve diğerleri
  Baskı/Yayın Bilgisi: (2021)
• Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)
  Yazar:: Mélanie Dos Santos, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-05-01)
• Leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan as individualized first-line therapy based on a drug sensitivity test
  Yazar:: OCHIAI, TAKUMI, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
  Yazar:: Garufi, C, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Serum iron levels as a new biomarker in chemotherapy with leucovorin and fluorouracil plus oxaliplatin or leucovorin and fluorouracil plus irinotecan, with or without molecularly-targeted drugs
  Yazar:: OCHIAI, TAKUMI, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)